CAT (60), CECR1 (61), GPI (62), HDGF (63), and MIF (53), previously reported to promote tumor development and progression, were specifically abundant in JAK3+TLR4+ CD16 monocytes, rather than JAK3-TLR4- CD16 monocytes (Figure 8E). The gene discussed is ADA2; the disease is neoplasm.